Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State by Joel LexchinPrivate Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State by Joel Lexchin

Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State

byJoel Lexchin

Paperback | September 21, 2016

Pricing and Purchase Info

$30.68 online 
$32.95 list price save 6%
Earn 153 plum® points
Quantity:

Ships within 1-3 weeks

Ships free on orders over $25

Available in stores

about

The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit?

In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years.

Joel Lexchin is a Fellow of the Canadian Academy of Health Sciences. He is a professor in the School of Health Policy and Management at York University and works as an emergency physician at the University Health Network.
Loading
Title:Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian StateFormat:PaperbackDimensions:384 pages, 9 × 6.06 × 0.9 inPublished:September 21, 2016Publisher:University of Toronto Press, Scholarly Publishing DivisionLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1442626593

ISBN - 13:9781442626591

Look for similar items by category:

Reviews

Table of Contents

Abbreviations

Boxes, Tables and Figures

Introduction: Why do we care about the pharmaceutical industry in Canada?

Chapter 1: (De)regulation through cooperation

Chapter 2: Biased testing, hidden results and the regulation of clinical trials

Chapter 3: Approving new drugs: better or just more?

Chapter 4: Regulating promotion or licensing deception?

Chapter 5: Health Canada and drug safety: how safe are we?

Chapter 6: Is intellectual property a right?

Chapter 7: How revenue is generated: prices, volume, mix and overall spending

Chapter 8: Who gets the value from research and development?

Chapter 9: Canada, the pharmaceutical industry and access to medicines in the Global South

Chapter 10: Courage my friends; 'tis not too late to build a better world

Acknowledgements

Editorial Reviews

"Private Profits versus Public Policy is a very interesting and well-referenced work. It offers a wealth of information in a field of work where hard information is difficult to gather."

- Nuria Homedes, School of Public Health, University of Texas